Loading...
Successful Multifold Dose Escalation of Anti-G(D2) Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study
PURPOSE: Pain can hinder immunotherapy with anti-G(D2) monoclonal antibodies (MoAbs) like 3F8. Heat-modified 3F8 (HM3F8) lacks effector functions and could mask G(D2) or cross-reactive epitopes on nerves, thereby preventing a subsequent dose of unmodified 3F8 from activating pain fibers. We hypothes...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3083872/ https://ncbi.nlm.nih.gov/pubmed/21343563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.28.3317 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|